65 VII, invitro diagnostics, reagents, test kits, & test sets, FSS contract award

Active Awarded Last action

Contract number
36F79724D0201
Awardee
Awarding agency
Task orders
2

Award facts

Opportunity
  • 65VII Solicitation number
Last date to order 44% complete
IDV ceiling
$5,124,839.00
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded a multiple-award Federal Supply Schedule contract under the General Services Administration's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) vehicle to supply molecular diagnostic reagents, test kits, and consumables to the Department of Veterans Affairs. The contract was awarded on September 1, 2024, with a ceiling value of $5.12 million and an ultimate completion date of August 31, 2029. The award incorporates a 2026 approved small business subcontracting plan and is funded by Veterans Integrated Service Network 12, a civilian component of the Department of Veterans Affairs. No set-aside designation was applied to this contract, consistent with Abbott Molecular's status as a large, established medical technology corporation. The contract supports the VA's molecular diagnostic testing infrastructure by providing specialized in-vitro diagnostic products, including Alinity M platform reagents and associated consumables for infectious disease screening and clinical laboratory operations.

Two delivery orders have been issued against this Federal Supply Schedule contract, demonstrating the contract's utility in supporting multiple Veterans Integrated Service Networks' testing requirements. Veterans Integrated Service Network 20 issued a delivery order valued at approximately $5.0 million for reagents and consumables for laboratory tests, with performance in Des Plaines, Illinois, extending through November 30, 2030. Veterans Integrated Service Network 4 issued a delivery order valued at $2.68 million on September 13, 2024, for sexually transmitted infection and SARS-CoV-2 testing supplies on the Alinity M platform, with completion scheduled for September 12, 2026. Both delivery orders utilize firm-fixed-price structures without set-aside designations and are performed at Abbott Molecular's Des Plaines facility. These task orders reflect the contract's critical role in maintaining diagnostic testing capabilities across the federal healthcare system for infectious disease screening and pandemic preparedness.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · Incorporating the 2026 approved small business subcontracting plan into the FSS contract. $0
Add Subcontract Plan P00001 · Commercial items (CHANGES) - SB subcontracting plan $0
Original award $0

Quick answers

Who was awarded contract 36F79724D0201?

36F79724D0201 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 1, 2024.

How much is contract 36F79724D0201 worth?

36F79724D0201's own ceiling is $5,124,839.

How many orders have been placed under contract 36F79724D0201?

2 orders have been placed under 36F79724D0201, the latest on December 1, 2025.

Who can order from contract 36F79724D0201?

36F79724D0201 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79724D0201 part of a contract vehicle?

Yes. 36F79724D0201 is part of Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract 36F79724D0201 competed?

The extent of competition for 36F79724D0201 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV